GSK
North America, Pennsylvania, United States, Kelayres
Description
GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
Investor Profile
GSK has backed more than 18 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
Stage Focus
- Series A (28%)
- Series B (22%)
- Series C (22%)
- Post Ipo Equity (11%)
- Series E (6%)
- Seed (6%)
- Series Unknown (6%)
Country Focus
- United States (72%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Switzerland (6%)
- Canada (6%)
- Sweden (6%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
- Medical
- Life Science
- Clinical Trials
- Health Diagnostics
- Oncology
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
